FDA Inspection 1224183 — Eurofins Amatsi Analytics
The FDA completed an inspection of Eurofins Amatsi Analytics on November 3, 2023 in Fontenilles. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fontenilles (France)
Additional Details
Bioanalytical BA/BE